BP programmes to prevent stroke worthwhile in Australia?

Author：

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.649, 2012-01, pp. : 6-6

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

SLNB or ALND for staging of EBC in Australia?

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 651, 2012-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

How best to prevent ischaemic stroke?

Inpharma, Vol. 1, Iss. 1268, 2000-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Statins: how do they prevent stroke?

Inpharma, Vol. 1, Iss. 1340, 2002-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Are Cancer Drugs Less Likely to be Recommended for Listing by the Pharmaceutical Benefits Advisory Committee in Australia?

By Chim Lesley Kelly Patrick J. Salkeld Glenn Stockler Martin R.

PharmacoEconomics, Vol. 28, Iss. 6, 2010-06 ,pp. : 463-475

Adis International

Access to resources Recommend Favorite

Is early intervention with biological agents worthwhile in RA?

Inpharma, Vol. 1, Iss. 1476, 2005-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite